SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-20-005863
Filing Date
2020-06-22
Accepted
2020-06-22 16:15:56
Documents
2
Period of Report
2020-06-18
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT admp-8k_061820.htm 8-K 35429
2 LETTER FROM MAYER HOFFMAN MCCANN P.C. ex16-1.htm EX-16.1 5218
  Complete submission text file 0001387131-20-005863.txt   41895
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 20978972
SIC: 2834 Pharmaceutical Preparations